azenta.com (AZTA) Company Sales

Corporate emblem and logo of azenta.com (AZTA)

Risks of reduced bio-research grants and logistics disruptions are weighing on Azenta, Inc. (AZTA) performance. The company's sales volume change illustrates daily revenue excluding accounting adjustments, where the latest value is recorded as 0.62. High costs for replacing storage systems create barriers for competitors, while the service of the legacy biosample base provides a stable, high-margin revenue stream.

AZTA azenta.com: Revenue and Sales Volume in the range 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Azenta (AZTA)

- share price and expert price forecast:
Price Performance Chart Brooks Automation|AZTA - Price Target Chart
- market capitalization details:
Market Valuation Azenta, Inc.|AZTA - Enterprise Value
- balance sheet equity data:
Net Asset Value per Share Azenta|AZTA - Book Capitalization|Capitalization to Book Value Ratio azenta.com|AZTA - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient Azenta, Inc.|AZTA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Azenta Inc|AZTA - Company Aggregate Debts|Debts to Book Capitalization Azenta, Inc.|AZTA - Company Long-Term Debt|Company Short-Term Debt Azenta|Intermediate Coverage Ratio azenta.com
- business earnings and investment ratios data:
AZTA - Net Profit|Expected Net Profit Azenta, Inc.|AZTA - Price to Earnings Ratio|Forward Price to Earnings Multiple azenta.com|AZTA - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Azenta, Inc.|AZTA - Operating profit EBITDA|Net earnings per share for the last four quarters Azenta|AZTA - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months azenta.com|AZTA - Earnings per share growth in current year|Expected earnings per share growth for next year Azenta, Inc.
- company sales and revenue statistics:
AZTA - Revenue and Sales Volume|Company Expected Sales Volume Brooks Automation|AZTA - Price-to-Revenue Ratio|Market Cap to Projected Revenue Azenta, Inc.
Summary company analysis:AZTA, Brooks Automation
Manufactured product of Azenta Life Sciences

Azenta, Inc. (AZTA) is undergoing a phase of structural business realignment following large-scale transformations. This indicator captures daily cash flow from service sales, bypassing quarterly reporting lags. By analyzing the company's sales dynamics, investors can observe real-time demand intensity. Steady growth in this line confirms the effectiveness of management's new strategy. This metric serves as an early signal for assessing the organic recovery of the business.

Analysis of competing companies

ABT: Company Sales Revenue|Company Revenue Thermo Fisher Scientific (TMO)|Company Sales gehealthcare.com GEHC|Revenue and Sales Volume MTD (Mettler Toledo)|Waters Corp (WAT) - Company Total Revenue|Techne Corporation - Revenue and Sales Volume|BRKR (Bruker BioSpin) - Company Sales Volume|VREX: Revenue and Sales Volume|SMLR - Company Gross Revenue|BFLY (Butterfly Network) - Revenue and Sales Volume|Company Sales Mesa Laboratories Inc (MLAB)|Revenue and Sales Volume QSI|Revenue and Sales Volume Nano-X Imaging Ltd (NNOX)|Company Revenue Quanterix Corporation QTRX|908devices.com - Company Revenue|CV: Company Sales|Company Sales Revenue MXCT (MaxCyte Inc.)|RPID: Revenue and Sales Volume|Company Total Revenue Seer Bio (SEER)|Company Revenue Hyperfine, Inc.|FONR - Company Total Sales Volume|Company Sales DXR (Daxor Corporation)|Revenue and Sales Volume Spectral AI Inc. (MDAI)|Revenue and Sales Volume VIVS (Organovo Holdings)|Company Gross Revenue Aclarion Corporation (ACON)|AKYA - Company Revenue|Company Annual Revenue THMO|talis.bio (TLIS) - Company Revenue|Company Sales T2 Biosystems Inc.